logo
header-image

OncoPharm

by JOHN BOSSAER
391 EPISODES
Aug 21
All Episodes
Venetoclax Dosing & APOLLO
JOHN BOSSAER
Zongertinib
JOHN BOSSAER
Dordaviprone & RCT to prevent ADRs
JOHN BOSSAER
ProMACE-CytaBOM
JOHN BOSSAER
Testicular Cancer in a Nutshell
JOHN BOSSAER
Supportive Care Updates
JOHN BOSSAER
Linvoseltamab & sunvozertinib
JOHN BOSSAER
Antiandrogen Withdrawal
JOHN BOSSAER
June 2025 Updates
JOHN BOSSAER
ASCO 2025
JOHN BOSSAER
CLEOPATRA
JOHN BOSSAER
Talking about cancer misinformation
JOHN BOSSAER
Four New Drugs
JOHN BOSSAER
Mg to Prevent Cisplatin Kidney Injury
JOHN BOSSAER
TI-CH, Updates on dostarlimab, ventoclax, & zongertinib
JOHN BOSSAER
BRCA Reversion Mutations
JOHN BOSSAER
HOPA 25 Recap
JOHN BOSSAER
Expanded Approvals for Durvalumab, Lu 177 vt; Portland Preview
JOHN BOSSAER
Topotecan
JOHN BOSSAER
API-CAT & IMPROVE
JOHN BOSSAER
Keynote 811 Update
JOHN BOSSAER
Polar: Cryotherapy or Compression to Prevent Taxane-induced neuropathy
JOHN BOSSAER
About Herb Drug Interactions
JOHN BOSSAER
Rethinking Premeds
JOHN BOSSAER
AMPLIFY
JOHN BOSSAER
OncoPharm M & M: Fatal TLS & Fatal T-cell lymphoma post-CAR-T
JOHN BOSSAER
[Re-release] Rituximab
JOHN BOSSAER
Acalabrutinb + BR and sotorasib + panitumumab
JOHN BOSSAER
Datoptamab deruxtecan
JOHN BOSSAER
Dex Dosing in MM, Tec-Tal, & postMONARCH
JOHN BOSSAER
Breakwater, Ensartinib, & SC Nivo
JOHN BOSSAER
The Accelerated Approval Pathway
JOHN BOSSAER
2024 New Drug Review
JOHN BOSSAER
A Feast Of Updates
JOHN BOSSAER
Zenocutuzumab
JOHN BOSSAER
Revumenib
JOHN BOSSAER
Anthracycline Use In Breast Cancer
JOHN BOSSAER
SWISH
JOHN BOSSAER
Zolbetuximab
JOHN BOSSAER
S1826 & INTERLACE
JOHN BOSSAER
Inavolisib
JOHN BOSSAER
Autumnal (2024) AML Updates
JOHN BOSSAER
MSI-High Rectal Cancer Treatment
JOHN BOSSAER
NATALEE + a slew of FDA updates
JOHN BOSSAER
ESMO 2024
JOHN BOSSAER
Doxorubicin + Trabectedin
JOHN BOSSAER
Chapter 1. Doses Matter
JOHN BOSSAER
Cross-Trial Comparison Don'ts
JOHN BOSSAER
Olanzapine For MEC
JOHN BOSSAER
Afamitresgene Autoleucel & Vorasidenib
JOHN BOSSAER